Related Experiment Videos
Antigen responsive antibody-receptor kinase chimera.
1Department of Chemical Engineering, Faculty of Engineering, University of Tokyo, Japan.
Bio/Technology (Nature Publishing Company)
|April 1, 1992
Summary
Researchers created a novel immunosensor by combining IgM and epidermal growth factor receptor (EGFR). Removing a specific IgM domain enabled antigen-dependent phosphorylation, paving the way for targeted signaling.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Background:
- Chimeric receptors integrate components from different proteins to create novel functionalities.
- Protein tyrosine kinase activity is crucial for cellular signaling pathways.
- Developing antigen-specific biosensors requires precise control over signaling events.
Purpose of the Study:
- To engineer a novel immunosensor with antigen-dependent phosphorylation activity.
- To investigate the role of specific domains in chimeric receptor function.
- To establish a system for detecting antigens through kinase activation.
Main Methods:
- Construction of chimeric receptors combining murine IgM and human epidermal growth factor receptor (EGFR) cytoplasmic domains.
- Utilizing intact and modified IgM (lacking CH2 domain) in chimeric constructs.
- Assessing protein tyrosine kinase activity in response to antigen (hapten-BSA) and antibody (anti-IgM) stimulation.
Main Results:
- Intact chimeric receptors exhibited constitutive, antigen-independent kinase activity.
- Chimeric receptors with IgM lacking the CH2 domain showed dose-dependent autophosphorylation upon stimulation.
- Monovalent hapten inhibited, rather than induced, phosphorylation, while conjugates stimulated activity.
Conclusions:
- The CH2 domain of IgM negatively regulates the kinase activity of the chimeric receptor.
- Modification of the IgM component is essential for achieving antigen-dependent phosphorylation.
- This engineered receptor system holds potential for developing targeted immunosensors.